European ADRs Gain Traction as Pharma Stocks See Mixed Fortunes

European ADRs Gain Traction as Pharma Stocks See Mixed Fortunes

American depository receipts of European stocks were 0.4% higher at 140.53 on the Bank of New York Mellon Europe ADR Index on Thursday morning.

Gainers in Continental Europe were led by Zealand Pharma ( ZEAL ), up by 12.1%, followed by CGG ( CGG ), a manufacturer of geophysical equipment, 5.2% higher and argenx ( ARGX ), a pharmaceutical company, up by 5.1%. Forward Pharma ( FWP ) was 3.7% higher.

In the UK, NuCana ( NCNA ), a biopharmaceutical company, was 5.4% higher, followed by BT Group (BT), a communications services company, 2.7% higher and Adaptimmune Therapeutics (ADAP), up by 1.7%. WPP (WPPGY), a provider of advertising and marketing services, was 1.6% higher.

Decliners in Continental Europe were led by VEON Com (VEON), a telecommunications services company, and Erytech Pharma (ERYP), both 1.5% lower, followed by DBV Technologies (DBVT), a French clinical-stage biopharmaceutical company, down by 1.3% and Telefonaktiebolaget LM Ericsson (ERIC), a telecommunications company, 0.5% lower.

And, in the UK, Ryanair (RYAAY), a low-cost airline, was 2.6% lower, followed by Carnival (CUK), a cruise vacation company, down by 1.7% and Barclays Bank – Series 5 Pref D(BCS PRD), down by 1.4%. AstraZeneca (AZN), a pharmaceutical company, was 1.3% lower.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

Related posts